Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 22

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 22
---
32 Depositary Shares at $46,400.00 per Depositary Share, (2) 12,931,020 Ordinary
Shares represented by 129 Depositary Shares, issuable upon the exercise of Series A warrants, or Series A Warrants, issued in the February
Private Placement at an exercise price of $53,600.00 per warrant, (3) 19,396,400 Ordinary Shares represented by 193 Depositary Shares,
issuable upon the exercise of Series B warrants, or Series B Warrants, issued in the February Private Placement at an exercise price
of $55,360.00 per warrant, and (4) 62,184,525 Ordinary Shares represented by 621 Depositary Shares, issuable upon the exercise of pre-funded
warrants issued in the February Private Placement at an exercise price of $8.00 per warrant, for aggregate gross proceeds of approximately
$6.0 million. We also issued unregistered warrants to the placement agent in the offering, or the February Placement Agent Warrants,
to purchase a total of 500,000 Ordinary Shares represented by five Depositary Shares to the placement agent at an exercise price of $58,000.00
per warrant, and Series A Warrants to purchase 625,000 ordinary shares represented by six Depositary Shares at an exercise price
of $53,600.00 per warrant to an investor pursuant to a waiver.

On March 27, 2023, following
shareholder approval, we effected a one-for-20 reverse stock split of our ordinary shares, and our ordinary shares began trading on AIM
on a split-adjusted basis as of such date. No fractional shares were issued in connection with the reverse stock split.

Concurrently with the
reverse stock split, and in an effort to bring the Depositary Shares price into compliance with NASDAQ’s minimum requirement for
500,000 listed Depositary Shares, on March 27, 2023, we effected a ratio change in the number of our Ordinary Shares represented by the
Depositary Shares from 25 Ordinary Shares per Depositary Share to five Ordinary Shares per Depositary Share. No fractional Depositary
Shares were issued.

| 14 |

Between March 27, 2023
and June 30, 2025, we have issued 95,137,075 Ordinary Shares upon the exercise of pre-funded warrants, Series A Warrants and Series B
Warrants issued in the February Private Placement.

On May 26, 2023